StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$6.24+0.75 (+13.76%)

Close on Nov 20, 2026Market cap $116.75MP/E –Yield –

Trinity Biotech gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $16.89M, down 21.2% from the year before. Over ten years it grew -9.6% a year on average. The highest annual figure on record is $48.58M in fiscal 2020.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$16.89M-21.2%
FY2024Dec 31, 2024$21.44M+10.2%
FY2023Dec 31, 2023$19.45M+12.6%
FY2022Dec 31, 2022$17.27M-48.4%
FY2021Dec 31, 2021$33.45M-31.1%
FY2020Dec 31, 2020$48.58M+27.4%
FY2019Dec 31, 2019$38.12M-8.0%
FY2018Dec 31, 2018$41.45M-1.1%
FY2017Dec 31, 2017$41.89M-3.7%
FY2016Dec 31, 2016$43.48M-6.5%
FY2015Dec 31, 2015$46.51M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018$10.81M–
Q2 FY2017Jun 30, 2017$10.82M–

More Trinity Biotech figures

See a number that looks wrong?